Skip to content

Jbs stock

JBSNYSE

Jbs N.V., Consumer DefensiveISIN NL0015002J37

$12.45▲ $0.05 (+0.4%)Closing price of 11 Nov 2026

54Score 54 out of 100, Neutral

We are checking this figure against the original source: debt.

Turn on early warning

Price and trend

58 / 100

Price history

−6.0% in one year

The chart shows daily closes over 1 year, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Below the 200-day line: the price is 11% below it.

Trend change

Since June 2026 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 51).

Distance to the high

The price is 32% below its 52-week high. Largest decline in 1 year: 41% (April 2026 to October 2026).

Chart figures for advanced users
SMA 50$12.35
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$13.99
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)51
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$10.86
The lowest closing price of the last twelve months.
Resistance$18.42
The highest closing price of the last twelve months.
Market cap
$27.62B
Div. yield
no dividend
17.0
Fair value
$13.56

Snapshot

Computed from the data by fixed rules, no AI

  • Jbs N.V. belongs to the Packaged Foods industry (Netherlands) and, with a market value of $27.62B, is number 6 of 75 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $84.79B (up 13% year on year) and earnings of $2B (up 15.4%).
  • MEQIRI Score 54 out of 100 (Neutral): rank 216 of 295 in Consumer Defensive, median 62.
Show more
  • The P/E is 17 (Packaged Foods median 18.7, own median of recent years 7.6).
  • Our model puts fair value at $13.56, with the price 8% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Share buybacksShare count down 60% since 2020.Capital allocation 70
  • Earnings per share growingUp 43.2% a year since 2020.Growth 54
  • Analysts expect strong earnings growthUp 37.8% a year through 2028 (estimates from 4 analysts).Growth 54

Weaknesses

  • High debtDebt 2.4 times equity (fiscal 2025), Packaged Foods median 0.65.Stability 41
  • Negative free cash flowFree cash flow −$185.96M over the last 12 months.Fundamentals 63
  • Margin fallingOperating margin 4.8%, average of the prior years 6.6% (to 2024).Profitability 41
54/ 100
MEQIRI Score
Neutral

Its standout strengths are valuation and capital allocation, while stability and momentum hold the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Score since yesterday from 52 to 54.

The fundamentals are in the middle range.

Profit consistency90% of years
Cash conversion (free cash flow to earnings, 12 months)−25%
ROIC (12 months)9.0%
Positive free cash flow100% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Valuation

Valuation signal

Fairly valued
Price
$12.45
Fair value
$13.56
Gap to fair value
−8%

In our model the price counts as cheap below $10.43 and expensive above $19.37 (uncertainty medium, based on the price swings of the past year).

The two parts of the fair value come to $13.40 (cash-flow model) and $13.71 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is slightly below both parts; given how much the stock swings, that still counts as fair.

Calculated with a cost of equity of 12.5%. At 13.5% the fair value would be $12.33, at 11.5% it would be $15.39.

Valuation metrics

0.45
6.8
Fair value (model)
$13.56
Earnings part $13.71 (earnings per share $0.73 × 18.7)

Half from the cash-flow model, half from earnings times the industry P/E (18.7).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

12 years

In the twelve months to 30 Sep 2026, revenue fell 19.1% on the twelve months before. Revenue has grown strongly since 2014, at around 13% per year.

Margins

12 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 13%, operating 5%, net 2%.

Debt & balance sheet

Fiscal 2025
2.4
2.6x
1.6
Cash & equivalents
$4.68B

Debt is elevated. Keep an eye on the interest burden and refinancing.

Earnings

Next earnings
24 Mar 2027in 132 days
Last reported
9 Nov 2026EPS reported 0.16 (expected 0.21)below expectations

Analyst estimates

Analysts have cut their 2027 earnings estimate by 4.7% since 15 Oct 2026. Falling estimates often precede bad news.

Fiscal 20267 analysts
Earnings per share
3.84−1.6%
Revenue
$86.62B−0.7%
Fiscal 20278 analysts
Earnings per share
6.83−4.7%
Revenue
$88.5B−0.9%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook confirmed

Share price after the results: −2.2%

Cattle availability is expected to recover in the first quarter of 2027 with slaughter volumes normal by the second quarter, and a cash flow breakeven EBITDA of $5.1 billion is cited for 2026, with no formal guidance change.

Supporting passage from the call, verbatim
“Not considering guidance but simply upgrading the cash flow breakeven EBITDA exercise for this year, we expect $5.1 billion in 2026, driven by capital expenditure of $2 billion in 2026, $400 million reduction versus the initial estimates.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 11 Aug 2026 (fiscal Q2 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases in the last 6 months. One insider sold, $2.54M in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Cavalcanti Guilherme PerboyreSale

    24 Aug 2026, Global CFO and IRO

    Shares
    183,501
    Price
    $13.85
    Value
    $2.54M

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Jbs

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

295 rated companies in Consumer Defensive

Rank 216 of 295
216/ 295
This company
54
Sector median
62

Categories against the sector median

ProfitabilityMedian of 295 companies41 (median 54)13 below the median
GrowthMedian of 295 companies54 (median 50)4 above the median
FundamentalsMedian of 295 companies63 (median 79)16 below the median
ValuationMedian of 290 companies with a value79 (median 65)14 above the median
StabilityMedian of 295 companies41 (median 68)27 below the median
Capital allocationMedian of 295 companies70 (median 62)8 above the median
Technical analysisMedian of 295 companies58 (median 65)7 below the median
MomentumMedian of 295 companies38 (median 60)22 below the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Packaged Foods

The next larger and next smaller companies by market value

All 75 Packaged Foods stocks

ETFs that hold Jbs

Held by 19 ETFs on Xetra. Shown per index: the ETF with the largest weight.

ETFWeightCostFund size
iShares MSCI Brazil UCITS ETF USD (Dist)IQQB0.96%0.74%€403.94M
iShares MSCI EM Latin America UCITS ETF USDIUSC0.49%0.20%€1.71B
iShares Edge MSCI EM Value Factor UCITS ETF5MVL0.37%0.40%€1.48B
Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 11 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = R$5.5565)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 12 Jun 2026)
  • Valuation signal Fairly valued since 10 Nov 2026, previously Undervalued
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy